Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Without price
ADC Telecommunica - [Ticker: ADCT]Chart ADC Telecommunica  News ADC Telecommunica  Download Historical Prices for Metastock ADC Telecommunica and Others  Technical Analysis ADC Telecommunica  
Last Trade0.00Last Trade Time - 00:00:00
VariationN/A (N/A)Open0.00
Volume0Average Volume (3m)0
YieldBid / AskN/A
Former Close0.0052 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
ADC Telecommunica -  [Ticker: ADCT] chart
Change to ADC Telecommunica Interactive Technical Analysis Chart

Last 10 Forum Topics about ADC Telecommunica:
No topics about ADC Telecommunica [ADCT] have been found, but a search on the Forum for more topics related to ADC Telecommunica is advised.

 News about ADC Telecommunica [ADCT]:   (ordered by relevance)
ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTAŽ (loncastuximab tesirine-lpyl) in Japan  Business Wire ADC Therapeutics SA (NYSE:ADCT) to Post FY2022 Earnings of ($3.06) Per Share, Cantor Fitzgerald Forecasts  MarketBeat 30 Stocks Moving In Friday's Mid-Day Session  Markets Insider Application Delivery Controller (ADC) Market to Witness Huge Growth by 2028 | A10 Networks Inc., Citrix Systems Inc., F5 Networks Inc.  Digital Journal ADC Therapeutics SA (ADCT) Q3 2021 Earnings Call Transcript  Motley Fool Lantern Pharma Announces Collaboration & Research Agreement with The Danish Cancer Society Research Center to Support Clinical Development of Drug Candidates, LP-100 and LP-184, in Solid Tumors  PRNewswire ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors  Business Wire Latest business liquidations in Unincorporated ACT  Daily Telegraph ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million  Business Wire ADC Therapeutics Announces Validation of its Marketing Authorization Application by the European Medicines Agency for ZYNLONTAŽ  Business Wire ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates  Business Wire Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTAŽ in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma  Business Wire ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTAŽ  Business Wire ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China and Singapore  Business Wire ADC Therapeutics Announces FDA Approval of ZYNLONTA? (loncastuximab tesirine-lpyl) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma  BioSpace ADC Therapeutics Announces Presentations at the 16th Annual International Conference on Malignant Lymphoma  Business Wire ADC Therapeutics Announces Encouraging Interim Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) Presented at the 16th Annual International Conference on Malignant Lymphoma  Business Wire ADC Therapeutics Announces Receipt of $50 Million Second Tranche of Convertible Credit Facility with Deerfield  Business Wire ADC Therapeutics to Present at Jefferies Virtual Healthcare Conference  Yahoo Finance ADC Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Updates  Business Wire Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China  PRNewswire Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer  Business Wire Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019  PR Newswire UK Coming together for Zynlonta  Cancer Research UK Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Board of Directors  Yahoo Finance ADC Therapeutics SA (NYSE:ADCT) Receives Consensus Recommendation of "Buy" from Analysts  MarketBeat ADC Therapeutics to develop anti-cancer drugs in new White City Campus centre  Imperial College London ADC Therapeutics Receives FDA Approval For Zynlonta  Contract Pharma ADC Therapeutics Announces the Termination of its ADCT-502 Program Targeting HER2 Expressing Solid Tumors  Business Wire 2022: Stakeholders call on Nigerians to participate in ICT/telecoms sector  Daily Sun ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S.  Business Wire Bergenbio dream lives on, despite Genmab's broken Axl  Vantage ADC Therapeutics Completes Enrollment in Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma  Business Wire ADC Therapeutics Announces FDA Accepts Biologics License Application and Grants Priority Review for Loncastuximab Tesirine for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma  Business Wire Fitch Affirms Liquid Telecom at 'B+'; Outlook Stable  Fitch Ratings 2023 Presidential Candidates: Hidden Hands Now Publicly Raised  Investors King Ltd Synaffix and Mersana add license options for six ADC targets to existing deal  The Pharma Letter A Pfizer partner welcomes ex-ADC Therapeutics CMO Jay Feingold to the team; Amid tough sledding, Immunovant chooses Eli Lilly alum as CFO  Endpoints News ADC Therapeutics Announces Pricing of Upsized Initial Public Offering  GlobeNewswire Camidanlumab Tesirine Under Investigation in Relapsed/Refractory Hodgkin Lymphoma  OncLive ADC Competition Heats Up In China But Caution, Pressure Also Mount  Scrip ADC Therapeutics Announces Proposed Public Offering  Business Wire Africa Data Centres Opens 10MW Colocation Facility in Lagos  Data Center Knowledge ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine (ADCT-402) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma  GlobeNewswire Manipur ADC Bill: ATSUM calls for 24-hr shutdown after talks fail -  EastMojo ADC Therapeutics Becomes Oversold (ADCT)  Nasdaq The European, Middle East and African Antitrust Review  Global Competition Review The proposed Manipur (hill areas) ADC bill, 2021 vis-ŕ-vis The Original Act  Nagaland Post ADC Therapeutics Announces Updated Clinical Data on Lead Antibody Drug Conjugate Programs Loncastuximab Tesirine (Lonca) and Camidanlumab Tesirine (Cami) Presented at 62nd American Society of Hematology Annual Meeting  Business Wire Liquid's ADC to build 'biggest African data centre' outside South Africa  Capacity Media ADC to pump billions into 10 new Africa data centres  TechCentral AstraZeneca helps ADCT to $200M megaround to push anticancer ADCs to pivotal data  FierceBiotech Lonza extends antibody drug conjugate supply deal with biotech client  Reuters Loncastuximab Tesirine Produces Durable Response in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma  Hematology Advisor ADC Therapeutics Doses First Patients in Pivotal Phase 2 Clinical Trial of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma  BioSpace Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders  PRNewswire Synaffix to Present Key ADC Technology Data on SYNtecan ETM Linker-Payload at World ADC Conference  PRNewswire ADC Therapeutics to Host Conference Call to Highlight Loncastuximab Tesirine (Lonca) Clinical Trial Data Being Presented at Virtual EHA Annual Congress  Business Wire ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield  GlobeNewswire TI's new precision wideband ADC pushes data-acquisition performance higher while cutting size and power consumption in half  PRNewswire ADC Therapeutics and Freenome Enter Biomarker Development  GlobeNewswire ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors  GlobeNewswire ADC Therapeutics Cuts Price In Second IPO Attempt  Seeking Alpha Genmab and ADC Therapeutics Announce Amended Agreement for  GlobeNewswire ADC Therapeutics Begins U.S. IPO Process  Seeking Alpha ADC's $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon  Xconomy ADC Therapeutics Announces Maturing Data from Pivotal Phase 2 Clinical Trial and Phase 1/2 Combination Clinical Trial of Loncastuximab Tesirine (Lonca) in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma  Business Wire IPO, check: Now, ADC Therapeutics files for lonca approval  FierceBiotech Byondis ESMO Late-Breaking Presentation Confirms ADC [Vic-] Trastuzumab Duocarmazine (SYD985) Superior to Physician's Choice in Pre-treated Locally Advanced or Metastatic HER2-Positive Breast Cancer  PRNewswire IPO Restart: ADC Therapeutics Refiles For U.S. IPO  TheStreet ADC Therapeutics to Participate in the Jefferies London Healthcare Conference  Business Wire The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business  Markets Insider New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients MilliporeSigma Announces New Innovation & Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies  Canada NewsWire ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio  PRNewswire The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference  Benzinga ADC Therapeutics cleared to resume US trial of camidanlumab tesirine  The Pharma Letter ADC Consortium to boost APAC IoT connections with new submarine cable  FutureIoT Innovent Announces License Agreement with Synaffix in an ADC Technology Deal  PRNewswire Synaffix collaboration with ADC Therapeutics expanded  The Pharma Letter ADC Therapeutics and Adagene Announce License Agreement  GlobeNewswire Seeking Alpha Catalyst Watch  Seeking Alpha ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker  GlobeNewswire Innovate with C#; Microsoft ADC Set to Host Programmers and Developers in Africa  PRNewswire Antibody-Drug Conjugates (ADCs) Market Size to Reach USD 20.01 Billion in 2028 | Increasing Prevalence of Cancer Along with Growing Geriatric Population are Significant Factor Driving Industry Demand, says Emergen Research  PRNewswire ADC Therapeutics (NYSE:ADCT) shareholders are up 10% this past week, but still in the red over the last year  Simply Wall St ADC Therapeutics set to go public  European Biotechnology Auto Scale your Applications with Citrix ADC on Google Cloud  ITPro Today Tyco Electronics to buy ADC Telecom for $1.25 billion  MarketWatch ADC Therapeutics taps Freenome to chart biomarkers for its lead lymphoma drug  FierceBiotech ADC Therapeutics Rakes in $303 Million with Addition to its Series E  BioSpace ADC Therapeutics Announces Final Close of Series E Financing Expansion  BioSpace DDB Worldwide Named 2021 Network of the Year by ADC  PRNewswire ATSUM takes ADC Bill demand to tribal villages : 18th oct21 Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers  PRNewswire Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021 - Benzinga  Benzinga ADC Therapeutics SA (ADCT) Stock Price Today, Quote & News  Seeking Alpha 3 Stocks At 52-Week Lows That Could Bounce Big - Benzinga  Benzinga FDA Approves Loncastuximab Tesirine for Relapsed/Refractory Large B-Cell Lymphoma  OncLive Identifying DLBCL Patients Most Likely to Benefit from ADCT-402 Goal of Partnership  Lymphoma News Today
For more news about ADC Telecommunica click here:
ADC Telecommunica News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources